Volume 27, Issue 2 (Iran South Med J 2024)                   Iran South Med J 2024, 27(2): 179-188 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abangah G, Sheikhi K. Prevalence of Common Risk Factors Between Gallstones and Non-Alcoholic Fatty Diseases in Patients Referred to the Gastroenterology Clinic of Shahid Mostafa Khomeini Hospital, Ilam in 2021. Iran South Med J 2024; 27 (2) :179-188
URL: http://ismj.bpums.ac.ir/article-1-2016-en.html
1- Department of Gastroenterology, School of Medicine, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran
2- Department of Gastroenterology, School of Medicine, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran , kosarsheikhi96@gmail.com
Abstract:   (848 Views)
Background: Gallstones are one of the most common problems of the biliary system, the best treatment of which is the traditional surgical removal of the gallbladder. Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GSD) secondary to the gallbladder are very common health problems worldwide. NAFLD and GSD share several risk factors, including age, ethnicity, and metabolic factors. Therefore, the aim of the present study is to investigate the prevalence of common risk factors between gallstones and non-alcoholic fatty liver disease in patients referred to the gastroenterology clinic of Shahid Mostafa Khomeini Hospital in Ilam.
Materials and Methods: In this descriptive study, cholecystectomy patients referred to the gastroenterology clinic of Shahid Mostafa Khomeini Hospital in Ilam were studied. The required data were collected by a researcher-made questionnaire with items on age, gender, type of surgery, emergency surgery, ultrasound findings, liver enzymes, BMI and severity of fatty liver. SPSS version 20 software was used for the statistical analysis of the data.
Results: This study included a total of 140 patients with a mean age of 41.12 years, and the majority of them (n=92, 65.7%) were women. The results showed that most of the surgeries performed in patients were of the conversion type, with a frequency of 84 (60%). A total of 55% of the patients did not have fatty liver and 17.1% were categorized in grade I of fatty liver disease, 19.3% were grade II and 8.6% were grade III. The mean alanine aminotransferase (ALT) (P <0.33) and aspartate aminotransferase (AST) (P<0.37) were lower in patients with conversion surgery compared to those who had undergone laparoscopic surgery, but this relationship was not statistically significant. The correlation of fatty liver severity with ALT was significantly positive in a direct way, and that of fatty liver severity with AST and ALP was direct but not significant. The correlation of gender with fatty liver and gallstones was direct but not in a statistically significant way; however, the correlation coefficient between liver enzymes and gallstones was significantly direct and positive. The correlation of BMI with fatty liver was direct, and with gallstones, it was indirect and negative, but not in a statistically significant manner. As BMI increased in patients with fatty liver, its grade also increased.
Conclusion: The results of the present study showed a direct relationship for gender, gallstones in cholecystectomy patients, and ALT with fatty liver, which suggests the higher prevalence of fatty liver in women. The mean ALT and AST were lower in patients with conversion surgery compared to laparoscopic surgery; therefore, it is recommended to conduct the study in a larger group over a longer period of time to achieve more accurate and effective results.
Full-Text [PDF 380 kb]   (377 Downloads)    
Type of Study: Original | Subject: Digestive System
Received: 2024/05/13 | Accepted: 2024/10/29 | Published: 2024/12/7

References
1. Barkun JS, Barkun AN, Meakins JL. Laparoscopic versus open cholecystectomy: the Canadian experience. The McGill Gallstone Treatment Group. Am J surg 1993; 165(4): 455-8. [DOI]
2. Williams LF Jr, Chapman WC, Bonau RA & et al. Comparison of laparoscopic cholecystectomy with open cholecystectomy in a single center. Am J Surg 1993; 165(4): 459-65. [DOI]
3. Hasukic S, Kosuta D, Muminhodzic K. Comparison of postoperative hepatic function between laparoscopic and open cholecystectomy. Med Princ Pract 2005; 14(3): 147-50. [DOI]
4. Lujan JA, Parrilla P, Robles R & et al. Laparoscopic cholecystectomy vs open cholecystectomy in the treatment of acute cholecystitis: a prospective study. Arch Surg 1998; 133(2): 173-5. [DOI]
5. Saber AA, Laraja RD, Nalbandian HI & et al. Changes in liver function tests after laparoscopic cholecystectomy: not so rare, not always ominous. Am Surg 2000; 66(7): 699-702. [Article]
6. St George A, Bauman A, Johnston A & et al. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2009; 50(1): 68-76. [DOI]
7. Tsuneto A, Hida A, Sera N & et al. Fatty liver incidence and predictive variables. Hypertens Res 2010; 33(6): 638-43. [DOI]
8. Bagheri Lankarani K, Ghaffarpasand F, Mahmoodi M & et al. Non alcoholic fatty liver disease in southern Iran: a population based study. Hepat Mon. 2013; 13(5): e9248. [DOI]
9. Lammert F, Gurusamy K, Ko CW & et al. Gallstones. Nat Rev Dis Primers 2016; 2: 16024. [DOI]
10. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol 2016; 65(1): 146-181. [DOI]
11. Sayiner M, Koenig A, Henry L & et al. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clin Liver Dis 2016; 20(2): 205-14. [DOI]
12. Adams LA, Lymp JF, St Sauver J & et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129(1): 113-21. [DOI]
13. Estes C, Razavi H, Loomba R & et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018; 67(1): 123-133. [DOI]
14. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006; 368(9531): 230- 9. [DOI]
15. Méndez-Sánchez N, Bahena-Aponte J, Chávez-Tapia NC & et al. Strong association between gallstones and cardiovascular disease. Am J Gastroenterol 2005; 100(4): 827-30. [DOI]
16. Riquelme A, Arrese M, Soza A & et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int 2009; 29(1): 82-8. [DOI]
17. Ahmed MH, Ali A. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?. Scand J Gastroenterol 2014; 49(5): 521-7. [DOI]
18. Housset C, Chrétien Y, Debray D & et al. Functions of the Gallbladder. Compr Physiol 2016; 6(3): 1549-77. [DOI]
19. Chiang JY. Bile acid metabolism and signaling. Compr Physiol 2013; 3(3): 1191-212. [DOI]
20. Kwak MS, Kim D, Chung GE & et al. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. World J Gastroenterol 2015; 21(20): 6287-95. [DOI]
21. Koller T, Kollerova J, Hlavaty T & et al. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol 2012; 47(2): 197-203. [DOI]
22. Loria P, Adinolfi LE, Bellentani S & et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42(4): 272-82. [DOI]
23. Fracanzani AL, Valenti L, Russello M & et al. Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. PLoS One 2012; 7(7): e41183. [DOI]
24. Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 2013; 108(6): 952-8. [DOI]
25. Nervi F, Arrese M. Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences? Am J Gastroenterol 2013; 108(6): 959- 61. [DOI]
26. Roesch-Dietlen F, Pérez-Morales AG, GrubePagola P & et al. Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico. Rev Gastroenterol Mex (Engl Ed) 2023; 88(3): 225-231. [DOI]
27. Yun S, Choi D, Lee KG & et al. Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis. World J Surg 2016; 40(6): 1412-21. [DOI]
28. Norozi S, Rai A, Salimi E & et al. The incidence of major cardiovascular events relied coronary vessels after angioplasty and stent types complications. Tehran Univ Med J 2018; 75(10): 722-729. (Persian) [Article]
29. Qavam S, Hafezi Ahmadi M R, Tavan H & et al. High-sensitive C-reactive protein in patients with acute coronary syndrome in statin therapy and its impact on prognosis. Tehran Univ Med J 2016; 74(4): 289-296. (Persian) [Article]
30. Tavan H, Sayehmiri K, Taghinejad H & et al. Factor Analysis of Spiritual Health on the Islam Viewpoint. Iran J Public Health 2015; 44(11): 1572-3. [Article]
31. Shohani M, Tavan H. Factors affecting medication errors from the perspective of nursing staff. J Clin Diagnos Research 2018; 12(3): IC01-IC04. [DOI]
32. Heidari Z, Sharafi Z. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iran South Med J 2022; 25(1): 30-41. [Article]

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Iranian South Medical Journal

Designed & Developed by: Yektaweb